Trials / Completed
CompletedNCT05608109
A Social Media Personalized Normative Feedback Intervention for Heavy Drinking College Students
Project Smash (Social Media Alcohol Session for Health)
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 401 (actual)
- Sponsor
- Duquesne University · Academic / Other
- Sex
- All
- Age
- 18 Years – 26 Years
- Healthy volunteers
- Accepted
Summary
This study seeks to evaluate the unique and synergistic efficacy of social media-specific personalized normative feedback targeting the reduction of alcohol use among heavy-drinking college students who post alcohol-related content on social media. Hypothesis: Alcohol personalized normative feedback, social media-specific personalized normative feedback, and the Alcohol personalized normative feedback+ social media-specific personalized normative feedback conditions will be more effective in reducing drinking than the attention control condition.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Alcohol personalized normative feedback (APNF) | Participants will receive individualized feedback based upon their survey responses. Feedback regarding participant's drinking compared to other same-university students will include: (a) drinking days per week, (b) average drinks per occasion, (c) drinks per week, and (d) drinking percentile rank. |
| BEHAVIORAL | Social media personalized normative feedback (SMPNF) | Participants will receive individualized feedback based upon their survey responses. Feedback regarding participant's alcohol related content posts on social media and drinking compared to other same-university students will include: (a) alcohol related posting days per week, (b) average alcohol related posting per week, (c) posting percentile rank, (d) drinking days per week, (e) average drinks per week, and (f) drinking percentile rank. |
Timeline
- Start date
- 2022-01-09
- Primary completion
- 2024-07-30
- Completion
- 2024-12-28
- First posted
- 2022-11-08
- Last updated
- 2025-02-03
Locations
3 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT05608109. Inclusion in this directory is not an endorsement.